L’ORÉAL DELVES FURTHER INTO GREEN SCIENCES WITH MINORITY STAKE BUY-OUT OF FRENCH BIOTECH MICROPHYT
THE WHAT? L’Oréal has announced a strategic partnership with French biotech Microphyt, which sees L’Oréal’s venture capital fund, BOLD (Business Opportunities for L’Oréal Development) acquire a minority stake in the firm.
THE DETAILS L’Oréal and Microphyt will build a technological platform and will bring material and human resources together to create raw materials from microalgae biomass.
“The ambition of both companies is to establish a long-term partnership for the development of new cosmetic solutions,” according to a press release.
The tie up comes after several strategic scientific partnerships recently forged by L’Oréal to strengthen its pioneering Green Sciences ecosystem of Beauty. These include the precision-health company VERILY, the National Institute for Materials Sciences (NIMS) in Japan, the Singapore Centre for Environmental Life Sciences Engineering (SCELSE) or the Laboratoire de Chimie des Polymères Organiques (LCPO) in Bordeaux.
THE WHY? According to a press release, “This partnership is an additional proof point of L’Oréal’s Research and Innovation strategy towards Greens Science and its investment in innovative biotech start-ups in France, and across the world.
“This proactive strategy is at the heart of L’Oréal’s 2030 sustainable development program, including the objective that 95% of its ingredients will be bio-sourced, derived from abundant minerals or from circular processes.”
Barbara Lavernos, Deputy CEO, in charge of Research, Innovation and Technology, L’Oréal Group, said: “Our ambition is to collaborate across the world with the most disruptive scientific entities in Green Sciences, in order to collectively develop responsible innovations on a large scale and make them available to as many people as possible.
“We are very pleased to pursue this new partnership with Microphyt, which will enable us, thanks to its unique natural solutions derived from microalgae, to further accelerate our drive towards more sustainable beauty.”
China agrochemical industry weekly(1202)
2026-08-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
ELC Opens New Advanced Biotech Center in Belgium
-
Unveiling the Challenges Faced by Biotech Companies in the Pharmaceutical Industry
-
Will China's Innovative Vaccine Breakthroughs Propel the Nation's Global Expansion?
-
Navigating the Changing Landscape of the Biotech Industry: Challenges and Opportunities
-
Will Biotech IPOs Regain Momentum in 2024?
-
Bridging Science and Business: Exploring the Dynamics of Biotech Innovation
-
Biotech Company FibroGen to Lay Off One-Third of American Staff in Cost-Cutting Move
-
Is the class solidified? From Biotech to Pharma
-
Ranked 9th! Guorui Biotech ranks among the forefront of China's CDMO enterprises in 2022
-
Biotech 'Death' List 2022: What Did They Do Wrong?
Recommend Reading
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
-
Novo Nordisk’s Oral Wegovy Wins EU Approval as Weight-Loss Competition Shifts from Injections to Pills
-
Ingredion Agrees to Acquire Tate & Lyle for $3.6 Billion, Reshaping the Global Specialty Ingredients Market
-
Wanhua Chemical and Xingfa Group Jointly Develop 5.32 Billion Yuan Phosphate Mine
-
Hormuz Crisis Pushes Up Urea Prices as Yara’s Quarterly EBITDA Jumps 39%
-
Strong Cost Support Drives Continued Strength in PTA Prices
-
Natural Rubber Market Trends Have Been Volatile and Consolidating Since July
-
China's SBR Prices Rise Driven by Costs
-
Insufficient Spot Buying Interest, Acrylonitrile Market Slips Again in China
-
Intensifying Long and Short Positions in Lithium Carbonate, Market Trends Downward